Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gout: can management be improved?

N Schlesinger1, H R Schumacher

  • 1Section of Rheumatology, UMDNJ/New Jersey Medical School, Newark, New Jersey 07103-2714, USA. schlesna@umdnj.edu

Current Opinion in Rheumatology
|May 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can characterization by traditional Korean medical criteria help in our understanding of patients with rheumatoid arthritis?

Clinical and experimental rheumatology·2005
Same author

Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.

Rheumatology (Oxford, England)·2005
Same author

Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Annals of the rheumatic diseases·2005
Same author

Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity.

Rheumatology (Oxford, England)·2004
Same author

Immunohistochemistry of normal human knee synovium: a quantitative study.

Annals of the rheumatic diseases·2004
Same author

Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease?

Clinical and experimental rheumatology·2004
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Limited randomized controlled trials exist for gout treatment. Lifestyle changes like diet and avoiding triggers, alongside medication considerations, are key for managing gout and reducing attacks.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Clinical Pharmacology

Background:

  • Cochrane reviews reveal a scarcity of high-quality randomized controlled trials for gout management.
  • Acute and chronic gout treatment decisions lack robust evidence.
  • Gout is a common comorbidity in transplant recipients, complicating management.

Purpose of the Study:

  • To review current evidence and highlight key considerations for gout treatment.
  • To discuss the role of lifestyle modifications and specific interventions in gout management.
  • To address the unique challenges of treating gout in transplant patients.

Main Methods:

  • Literature review of existing studies on gout treatment.
  • Analysis of factors contributing to gouty attacks.

Related Experiment Videos

  • Evaluation of medication effects on serum uric acid levels.
  • Consideration of dietary interventions for gout patients.

    • Main Results:

    • Limited reliable data from randomized controlled trials exists for gout treatment.
    • Avoiding triggers like diuretics, weight gain, and alcohol may decrease gouty arthritis.
    • Minidose aspirin's effect on serum uric acid requires further attention.
    • Low-carbohydrate, high-protein diets with unsaturated fats may reduce serum uric acid by enhancing insulin sensitivity.

    Conclusions:

    • There is a critical need for more high-quality randomized controlled trials in gout management.
    • Lifestyle modifications and dietary changes are important adjuncts to pharmacotherapy.
    • Managing gout in transplant recipients presents specific challenges requiring careful consideration.